Abstract
Aim. To study of the effectiveness of the drug mesodiethylethylendibenzosulfonate (Sagenit) in women with urination disorders in the climacteric period. Methods. During the years 2009-2010 at the Department of Urology and Nephrology of Altai State Medical University were examined, treated and followed-up 40 women of the climacteric period (aged 43 to 64 years) with urination disorders. All patients were prescribed Sagenit, 1 tablet a day for 1-6 months. Results. Sagenit was well tolerated by female patients for a long period of time, had no significant side effects, which would require discontinuation of the drug. After the conducted treatment the time of urination lengthened, the volume of urination increased and the maximal urinary flow rate decreased. The positive effect of therapy (improvement of the quality of life) was reported by 75% of the surveyed women. Conclusion. Sagenit was shown to be effective in treating women with urination disorders in climacteric period.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
